RareCyte
RareCyte develops spatial proteomics and liquid biopsy platforms for researchers, biopharma companies and clinical research teams. Its Orion platform profiles multiple markers in tissue, while CyteFinder detects rare cells, including circulating tumor cells, in blood samples to support biomarker development and precision biology.
Facts
- HQ
- Seattle
- Sectors
- Biotechnology Research
- Founded
- 2009
- Employees
- 62
- Members see funding amounts. .
Is this your organization? Claim it
RareCyte raises $24M to commercialize Orion 21-channel high-speed cell imaging platform
Seattle startup RareCyte raised $24 million to commercialize and expand its Orion high-speed, 21-channel fluorescent cell imaging and analysis platform and other automated biopsy products for researchers and biopharma.
People
-
Ronald Seubert Founder
-
Joe Victor Executive, CEO